FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma Promega MSI technology will aid in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results